Innospark Ventures — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Fourier Optics builds Fourier AR, an angular and wavelength-selective metasurface optical combiner embedded invisibly inside ophthalmic lenses that reflects RGB light from a µLED projector to the eye for all-day augmented-reality glasses.
Deep TechHardwareSemiconductors
Dr. Omri Barlev(Founder & CEO)Shoam Shwartz(Founder & CTO)inAsaf Carmel(Founder & VP R&D)in
BoardJoe O'keeffe(Chairman)
Co-investorsMaverick Ventures IsraelLam Capitalfresh.fundLasagnaNextGen Venture PartnersTAU Ventures+1 more
Fourier Health builds infrastructure to unlock unstructured clinical data from healthcare systems, enabling AI models and clinicians to access actionable intelligence from records currently locked in PDFs and fragmented systems.
AI & Machine LearningData & InfrastructureDigital HealthHealthtech
Christopher Lee(Co-Founder & CEO)inJames Lloyd(Co-Founder & CTO)in
Co-investorsGeneral CatalystNextGen Venture PartnersNextLeap VenturesTau VenturesLasagnaMyelin VC+1 more
Juniper Genomics provides genomic testing for IVF, including enhanced PGT-A that analyzes both DNA and RNA from a single embryo biopsy to assess chromosome status and embryo viability, and PGT-G that expands analysis across nearly the full genome from the same sample.
BiotechDigital HealthFemTech
Co-investorsAmboy Street VenturesDria VenturesBlue CollectiveCompany VenturesMBX Capital
All-in-one AI vision system enabling autonomous operation and quality control in plastic injection molding.
Edward Schneeweiss(Founder)inSebastian G Schneeweiss(Founder)in
Co-investorsArgon VenturesBlue CollectiveGlasswing VenturesFounder Collective
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





.png)






